Fall Course 2020
ISSWSH Annual Meeting 2021

ISSWSH is a multidisciplinary, academic, and scientific organization whose purposes are:

To provide

opportunities for communication among scholars, researchers, and practitioners about women's sexual function and sexual experience...

To support

the highest standards of ethics and professionalism in research, education, and clinical practice of women's sexuality, and ...

To provide

the public with accurate information about women's sexuality and sexual health.

UPCOMING MEETING

ISSWSH Sexual Pain Course 2020

April 17-18, 2020
CANCELLED DUE TO COVID-19
Read more...

ISSWSH Fall Course 2020

November 19-21, 2020   235 days left
DoubleTree Hilton Hotel, Scottsdale, AZ, USA
Read more...

ISSWSH Annual Meeting 2021

March 4-7, 2021   340 days left
Renaissance Dallas Hotel, Dallas, TX, USA

LATEST NEWS

ISSWSH Cancels Sexual Pain Course April 17-18, 2020 in Washington DC

ISSWSH has decided to cancel the ISSWSH Sexual Pain Course scheduled for April 17-18, 2020 in Washington D.C. in direct response to the novel coronavirus (COVID-19) outbreak which is now identified as a pandemic. ISSWSH is concerned for the health and safety of our faculty and attendees and recognizes that there are an increasing number of academic institutions restricting travel which affects people’s ability to attend. For more information on this cancellation and any questions you may have, please visit: https://www.isswshcourse.org/spring2020/covid-19/cancellation

ISSWSH Welcomes New President – Dr. Noel N. Kim

At the 2020 Annual Business Meeting, ISSWSH welcomed Dr. Noel N. Kim, PhD, IF, Senior Investigator at the Institute for Sexual Medicine in San Diego and associate editor of Sexual Medicine Reviews (SMR), as its new president for a two-year term 2020-2022. He previously served as the Assistant Director of the Laboratory for Sexual Medicine Research at the Boston University School of Medicine and was a member of the editorial board of The Journal of Sexual Medicine for the first decade of the journal through 2014. From 2007, Dr. Kim served for 5 years as Chief Scientific Officer of Alagin Research, a biotechnology company devoted to developing therapeutics and diagnostics in sexual medicine. Dr. Kim continues to serve as a consultant to other companies developing therapies for sexual dysfunction. Dr. Kim most recently served as the society’s President-Elect, and Treasurer before that.

Read more ...
ISSWSH ISSUES IMPORTANT UPDATES FOR HSDD THERAPIES

ISSWSH is pleased to provide the following updates related to therapies for Hypoactive Sexual Desire Disorder or HSDD. The FDA has updated prescribing information for flibanserin, removed the REMS certification requirement for prescribers and pharmacists, and updated safety information related to the alcohol contraindication. In addition, bremelanotide has now been approved for treatment of HSDD. Please see the attached news release related to these two therapies for more specific information and references.

News Release

Latest Tweets

“No research can be truly meaningful if there is not a regulatory agency that will allow developers to put forward… https://t.co/lGlT88qH4U ISSWSH
Time to Orgasm in Women in a Monogamous Stable Heterosexual Relationship was 13 minutes in this study. https://t.co/3ovAvTUcRa ISSWSH
Endometriosis apps include symptom trackers, education, & support for women w/this condition. Do apps have a role i… https://t.co/4T9KMOVJm3 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!